Depressive Disorder, Major: all 2,805 studies

Page 9 of 29. Open to participants first (565), then studies with results posted, then the rest; newest registration first within each.

• An Efficacy and Safety Study of Sirukumab in Participants With Major Depressive DisorderCompletedNCT02473289Phase 2Results posted
• Trial of Levomilnacipran in Geriatric DepressionCompletedNCT02466958Phase 4Results posted
• Ketamine for the Rapid Treatment of Major Depressive Disorder and Alcohol Use DisorderCompletedNCT02461927Phase 1/2Results posted
• Brain Connectivity and Response to Tai Chi in Geriatric DepressionCompletedNCT02460666Not applicableResults posted
• eIMPACT Trial: Modernized Collaborative Care to Reduce the Excess CVD Risk of Older Depressed PatientsCompletedNCT02458690Phase 2Results posted
• Low Field Magnetic Stimulation (LFMS) in Subjects With Treatment-Resistant Depression (TRD)CompletedNCT02452892Not applicableResults posted
• A Study of Vilazodone in Pediatric Patients With Major Depressive DisorderCompletedNCT02436239Phase 3Results posted
• Safety and Efficacy of Levomilnacipran ER in Adolescent Participants With Major Depressive DisorderCompletedNCT02431806Phase 3Results posted
• Effects of Low Dose Ketamine Given at Induction of Anesthesia on Postoperative Mood in Patients With Depressive SymptomsTerminatedNCT02422303Not applicableResults posted
• miRNAs, Suicide, and Ketamine - Plasma Exosomal microRNAs as Novel Biomarkers for Suicidality and Treatment OutcomeCompletedNCT02418195Phase 2Results posted
• Influenza Challenge in Mood DisordersTerminatedNCT02415166Not applicableResults posted
• A Multi-level Life-span Characterization of Adult-depression and Effects of Medication and ExerciseCompletedNCT02407704Phase 4Results posted
• Supported Employment in Patient Aligned Care TeamsCompletedNCT02400736Not applicableResults posted
• Evaluation of the Safety of Adjunct Brexpiprazole in Elderly Patients With Major Depressive Disorder and an Inadequate Response to Antidepressant TreatmentCompletedNCT02400346Phase 3Results posted
• A Phase II Study of PDC-1421 Capsule to Evaluate the Safety and Efficacy in Patients With Major Depressive DisorderCompletedNCT02395978Phase 2Results posted
• A Phase 3 Study of Lu AA21004 in Patients With Major Depressive DisorderCompletedNCT02389816Phase 3Results posted
• Behavioral Activation and Varenicline for Smoking Cessation in Depressed SmokersCompletedNCT02378714Phase 4Results posted
• Improving Therapeutic Learning in Depression: Proof of ConceptCompletedNCT02376257Phase 2Results posted
• Safety and Efficacy of Vilazodone in Pediatric Patients With Major Depressive Disorder (VLZ-MD-22)CompletedNCT02372799Phase 3Results posted
• Vortioxetine, 5, 10, and 20 mg, Relapse Prevention Study in Adults With Major Depressive Disorder (MDD)CompletedNCT02371980Phase 4Results posted
• 5-hydroxytryptophan and Creatine for Treatment Resistant Depression Associated With Hypoxia in FemalesCompletedNCT02356107Phase 4Results posted
• Transcranial Alternating Current Stimulation for Major Depressive DisorderCompletedNCT02339285Not applicableResults posted
• Connectivity Affecting the Antidepressant REsponse StudyCompletedNCT02332291Phase 4Results posted
• A Multicenter, Relapse Prevention Study With Levomilnacipran Extended Release (ER) in Participants With Major Depressive DisorderCompletedNCT02288325Phase 4Results posted
• rTMS for PTSD Comorbid With Major Depressive DisorderCompletedNCT02273063Not applicableResults posted
• Study to Assess Clinical Response of Duloxetine in Patients Hospitalized for Severe DepressionCompletedNCT02229825Phase 4Results posted
• A Study of ALKS 5461 for the Treatment of Major Depressive Disorder (MDD) - FORWARD-5 StudyCompletedNCT02218008Phase 3Results posted
• Clinical Study of Generic and Brand Bupropion in DepressionCompletedNCT02209597Phase 4Results posted
• Study of the Safety and Efficacy of Fixed-dose Brexpiprazole (OPC-34712) as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder With and Without Anxious DistressCompletedNCT02196506Phase 3Results posted
• Open Label Extension for GLYX13-C-202, NCT01684163TerminatedNCT02192099Phase 2Results posted
• Study to Evaluate the Efficacy, Safety and Tolerability of Bupropion Hydrochloride Extended-release Tablet, and Escitalopram Oxalate Capsule in Subjects With Major Depressive DisorderCompletedNCT02191397Phase 3Results posted
• Fixed Dose Intervention Trial of New England Enhancing Survival in SMI PatientsCompletedNCT02188121Phase 4Results posted
• Double-blind Pilot Trial of Mirtazapine for the Treatment of Co-occurring AD/MDD.CompletedNCT02185131Phase 2Results posted
• Buprenorphine Used With Treatment Resistant Depression in Older AdultsCompletedNCT02181231Phase 1/2Results posted
• Efficacy of Adjunctive Exercise for the Behavioral Treatment of Major DepressionCompletedNCT02176408Not applicableResults posted
• Incomplete Response in Late-Life Depression: Getting to Remission With BuprenorphineCompletedNCT02176291Phase 2Results posted
• IntelliCare: Artificial Intelligence in a Mobile Intervention for Depression and Anxiety (AIM)CompletedNCT02176226Not applicableResults posted
• A Study of ALKS 5461 for the Treatment of Major Depressive Disorder (MDD) - the FORWARD-3 StudyCompletedNCT02158546Phase 3Results posted
• A Study of ALKS 5461 for the Treatment of Major Depressive Disorder (MDD) - the FORWARD-4 StudyCompletedNCT02158533Phase 3Results posted
• Study to Treat Major Depressive Disorder (MDD) With a New MedicationCompletedNCT02149836Phase 2Results posted
• Automatic Self Transcending Meditation Versus Treatment as UsualCompletedNCT02149810Not applicableResults posted
• A Long-Term Safety Study of ALKS 5461CompletedNCT02141399Phase 3Results posted
• Nitrous Oxide as Treatment for Major Depression - a Pilot StudyCompletedNCT02139540Phase 2Results posted
• Creatine Augmentation for Adolescent Females With Treatment-Resistant Major Depressive DisorderCompletedNCT02134808Phase 4Results posted
• A Double-blind Study to Assess the Efficacy and Safety of Intranasal Esketamine for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Participants Who Are Assessed to be at Imminent Risk for SuicideCompletedNCT02133001Phase 2Results posted
• OnabotulinumtoxinA as Treatment for Major Depressive Disorder in Adult FemalesCompletedNCT02116361Phase 2Results posted
• Genomics Used to Improve DEpression DecisionsCompletedNCT02109939Not applicableResults posted
• A Study of Different Titration Schedules of ALKS 5461 in Adults With Major Depressive Disorder (MDD)CompletedNCT02085135Phase 3Results posted
• Developing New Clinical Management StrategiesCompletedNCT02082392Phase 4Results posted
• Effect of Amygdala Neurofeedback on Depressive Symptoms and Processing BiasesCompletedNCT02079610Not applicableResults posted
• Ketamine in Adolescents With Treatment-Resistant DepressionCompletedNCT02078817Phase 2Results posted
• A Randomized Controlled Trial of PCIT-ED for Preschool DepressionCompletedNCT02076425Not applicableResults posted
• Adjunctive Mixed Salts Amphetamine for Depressed Adults With Incomplete Response to Current Antidepressant TherapyCompletedNCT02058693Phase 4Results posted
• Assess the Efficacy and Safety of ASC-01 in Patients With Major Depressive DisorderCompletedNCT02046564Phase 3Results posted
• Imaging Dopamine Release in DepressionCompletedNCT02033369Phase 4Results posted
• Switching From Generic Selective Serotonin Reuptake Inhibitors (SSRIs) and Selective Serotonin and Norepinephrine Reuptake Inhibitors (SNRIs) to Three Different Dose Initiation Strategies With VilazodoneCompletedNCT02015546Phase 3Results posted
• Safety and Efficacy Study Comparing ETS6103 With Amitriptyline in the Treatment of Major Depressive Disorder (MDD)CompletedNCT02014363Phase 2Results posted
• Brexpiprazole (OPC-34712) as an Adjunctive Treatment in Active Adults, 18 to 35 Years Old, With Major Depressive Disorder Who Are in a School or Work EnvironmentCompletedNCT02013609Phase 3Results posted
• Brexpiprazole (OPC-34712) as an Adjunctive Treatment in Adults With Major Depressive Disorder and Anxiety SymptomsCompletedNCT02013531Phase 3Results posted
• Brexpiprazole as Adjunctive Therapy With Major Depressive Disorder and an Inadequate Response to Previous Adjunctive TherapyCompletedNCT02012218Phase 3Results posted
• Brain Mechanisms of Human MotivationCompletedNCT01976975Results posted
• Evaluation of a Mental Health Physician Support Program in Nova ScotiaCompletedNCT01975948Not applicableResults posted
• Antidepressant Response in the Treatment of Depressive Symptoms and Frailty Characteristics in Older AdultsCompletedNCT01973283Phase 4Results posted
• Efficacy of Extended-release Quetiapine (Seroquel XR) as Adjunctive Therapy to Cognitive Behavioral Therapy in the TreatCompletedNCT01971203Not applicableResults posted
• A Study to Investigate Evoked Potentials as Markers of Ketamine-induced Cortical Plasticity in Patients With Major Depressive DisorderTerminatedNCT01957410Phase 2Results posted
• Transdiagnostic Psychotherapy for Veterans With Mood and Anxiety DisordersCompletedNCT01947647Not applicableResults posted
• Long-term Safety and Tolerability Study of Brexpiprazole as Adjunctive Treatment in Patients With Major Depressive DisorderTerminatedNCT01944969Phase 3Results posted
• Study of Brexpiprazole as Adjunctive Treatment of Irritability in Patients With Major Depressive Disorder and an Inadequate Response to Antidepressant TherapyCompletedNCT01942785Phase 3Results posted
• Investigation of Brain Network Dynamics in DepressionCompletedNCT01931995Not applicableResults posted
• Mechanisms of Antidepressant Non-Response in Late-Life DepressionCompletedNCT01931202Not applicableResults posted
• Predictors of Treatment Outcome With Cognitive Behavioral Therapy for DepressionCompletedNCT01922219Not applicableResults posted
• Placebo Effects in the Treatment of Depression: Cognitive and Neural MechanismsCompletedNCT01919216Phase 4Results posted
• Effects of Treatment on Decision-making in Major DepressionCompletedNCT01916824Phase 4Results posted
• Frontal Hypoperfusion Effects on Antidepressant Outcomes in Late-Life DepressionCompletedNCT01896934Phase 4Results posted
• Nuedexta in Treatment-Resistant Major DepressionCompletedNCT01882829Phase 2Results posted
• Safety and Efficacy of Vilazodone in Adolescent Patients With Major Depressive DisorderCompletedNCT01878292Phase 3Results posted
• Memantine Plus Es-citalopram in Elderly Depressed Patients With Cognitive ImpairmentCompletedNCT01876823Phase 2/3Results posted
• Low-Dose Naltrexone (LDN) for Depression Relapse and RecurrenceCompletedNCT01874951Phase 2Results posted
• A Study to Evaluate the Impact of Escitalopram on Quality of Life and Social Functionality in Patients With Major Depressive Disorder With Anxiety SymptomCompletedNCT01870843Phase 4Results posted
• Efficacy and Safety Study of NeuroStar TMS Therapy in Patients With Major Depressive Disorder With Postpartum OnsetTerminatedNCT01842542Not applicableResults posted
• Long-term Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy in Patients With Major Depressive DisorderCompletedNCT01838876Phase 3Results posted
• Brexpiprazole as Adjunctive Treatment in Patients With Major Depressive Disorder With an Inadequate Response to Antidepressant TreatmentCompletedNCT01838681Phase 3Results posted
• Efficacy and Safety of Brexpiprazole as Adjunctive Treatment in Elderly Patients With Major Depressive Disorder With an Inadequate Response to Antidepressant TreatmentTerminatedNCT01837797Phase 3Results posted
• Brain Imaging of rTMS Treatment for DepressionCompletedNCT01829165Not applicableResults posted
• A Study of Fluoxetine in Major Depressive Disorder (MDD) Long-Term DosingCompletedNCT01808651Phase 3Results posted
• A Study of Fluoxetine in Major Depressive Disorder (MDD) Short-Term DosingCompletedNCT01808612Phase 3Results posted
• rTMS for Depressed Teens: A Sham-Controlled Trial, Part 2TerminatedNCT01804296Not applicableResults posted
• rTMS for Depressed Teens: A Sham-Controlled Trial, Part 1TerminatedNCT01804270Not applicableResults posted
• Neurobiological Bases of Placebo Response in Major Depressive DisorderTerminatedNCT01787240Phase 4Results posted
• A Dose Escalation Phase I Study of PDC-1421 Capsule Targeting in DepressionCompletedNCT01774045Phase 1Results posted
• Open Trial of Duloxetine in Outpatients With Irritable Bowel Syndrome Symptoms and Co-Morbid Major DepressionCompletedNCT01754493Phase 4Results posted
• Mommy-Baby Treatment for Perinatal DepressionCompletedNCT01744041Not applicableResults posted
• Double-Blind Treatment of Major Depressive Disorder With VilazodoneCompletedNCT01742832Phase 2Results posted
• Comparison of Behavioral Activation and Antidepressant Medication in the Treatment of Adolescents With DepressionTerminatedNCT01740726Not applicableResults posted
• Transcranial Magnetic Stimulation for Adolescent DepressionCompletedNCT01731678Not applicableResults posted
• Study of Lurasidone in Treating Antipsychotic Naive or Quasi-Naive Children and AdolescentsCompletedNCT01731119Phase 2Results posted
• A Study of Flexible-dose Brexpiprazole as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder, the Delphinus TrialCompletedNCT01727726Phase 3Results posted
• Study to Evaluate the Effect and Safety of Quetiapine Extended Release (XR) (FK949E) in Major Depressive DisorderCompletedNCT01725282Phase 2Results posted
• Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)CompletedNCT01715805Phase 3Results posted
• Riluzole Augmentation Pilot in Depression (RAPID) TrialTerminatedNCT01703039Phase 2Results posted

← Depressive Disorder, Major overview